Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Anticancer agent 122, a potent inhibitor of human lactate dehydrogenase A (h LDHA), exhibits significant anticancer activities, rendering it suitable for use in cancer research [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Anticancer agent 122, a potent inhibitor of human lactate dehydrogenase A (h LDHA), exhibits significant anticancer activities, rendering it suitable for use in cancer research [1]. |
In vitro | Anticancer agent 122 (Compound 8m) at concentrations of 0-100 μM over 72 hours inhibits the growth of liver cancer cells (HepG2) and cervical cancer cells (SiHa) with IC50 values of 5.15 μM and 1.65 μM, respectively, and exhibits no significant toxicity toward the human embryonic kidney cell line (HEK293) [1]. |
Molecular Weight | 358.84 |
Formula | C18H15ClN2O2S |
CAS No. | 2924532-50-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Anticancer agent 122 2924532-50-1 inhibitor inhibit